ZURA

Conviction 47HealthcareScan · Thu, Jun 25, 2026

ZURA$4.54+6.57%

ResistanceSupportVol 14

Vol MA14 1.26M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Zura Bio LtdBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.zurabio.com ↗

Price4.54

Change+6.57%

Gap+2.58%

Rel volume2.01×

Avg volume1.11M

Avg $ vol4.26M

SMA 203.89

SMA 504.53

SMA 2004.68

Price vs 50+0.32%

Price vs 200-3.03%

MA stackmixed

50/200 crossdeath · 4d

Supertrendup · 3.60

RSI (14)60

MACD hist0.14

MACD crossbull · 8d

Stoch %K / %D92 / 91

ADX (14)30

+DI / −DI29 / 18

RSI divergence—

MACD divergence—

ATR %+6.58%

ADR %6.87%

52w high7.04

52w low1.05

From 52w high-35.51%

Above 52w low+332.38%

New 52w highNo

SqueezeOff

Bollinger width34.61%

%B0.99

Donchian pos91.81%

Donchian high4.66

Donchian low3.25

AVWAP (52w high)4.78

vs AVWAP high-5.00%

AVWAP (52w low)4.03

vs AVWAP low+12.63%

OBV trendFlat

Chaikin MF (20)-0.00

Today vs 20d2.01×

Avg vol (14d)1.26M

Avg vol (20d)1.11M

Avg $ vol (20d)4.26M

Market cap431.29M

RS 3m (vs SPY)-33.07%

RS 6m (vs SPY)-7.97%

RS line new highNo

Trend template4/8

Technical rank55.1

1 week+25.41%

1 month+7.84%

3 months-19.22%

6 months+4.37%

1 year+275.21%

YTD-18.20%

P/E-6.28

P/B4.25

P/S—

P/FCF-6.64

EPS-1.06

Div yield—

ROE-67.61%

ROA-30.03%

Debt/Eq—

Current19.33

EV/EBITDA-2.74

Gross margin—

Net margin—

Rev growth—

EPS growth-31.00%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value205.7M

Revenue—

Net income-24.22M

Gross profit—

Free cash flow-64.93M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out95M

Employees40

ListedTue, Mar 21, 2023

Free float52.02M

Float %54.8%

Short interest6.22M

Days to cover9.1d

Short volume60.0%

Squeeze score77 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank55.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.25

Support3.37

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ZURA

All disclosures →

No recent disclosed trades by Congress in ZURA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ZURA · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Thiara Parvinder Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Schoch Steven J Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Nirula Ajay Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Eisner Mark Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Jarrett Jennifer Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Munshi Amit Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Becker Daniel J. Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22

SEC filings

EDGAR filings in ZURA · 1 recent

EDGAR →

8-K8-KThu, Jun 18, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.